Accelerate Diagnostics Growth, Revenue, Number of Employees and Funding

Overview

Location:
Tucson, AZ USA
Total Funding:N/A
Industry:Medical Equip
Founded:2004
Lead Investor(s):N/A
Press

Estimated Revenue & Financials

  • Accelerate Diagnostics's estimated revenue is currently $56.7M per year.
  • Accelerate Diagnostics's estimated revenue per employee is $234405

Employee Data

  • Accelerate Diagnostics has 242 Employees.
  • Accelerate Diagnostics grew their employee count by -4% last year.
  • Accelerate Diagnostics currently has 1 job openings.

What Is Accelerate Diagnostics?

Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The company's revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the ID/AST development pipeline, the company also owns and licenses its proprietary OptiChem surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.

keywords:N/A

242

Number of Employees

$56.7M

Revenue (est)

1

Current Jobs

-4%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
AdviNow Medical
$8M3417%$2.5M
Accelerate Diag...
$56.7M242-4%
SynCardia Syste...
$22.3M952%
Auer Precision ...
$8M346%
Life Care Solut...
$9M390%
Cranial Technol...
$66.3M28216%
WestPac Surgica...
$10.3M4426%

Accelerate Diagnostics News

09/03/2019 - Accelerate Diagnostics Reports Second Quarter 2019 ...

TUCSON, Ariz., Aug. 8, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second ...

08/09/2019 - Accelerate Diagnostics, Inc.: The Snowball Effect Is Just ...

Accelerate Diagnostics (NASDAQ:AXDX) is finally approaching an inflection point in their unit sales of the Pheno system, and hospitals are ...

09/03/2019 - Putting Accelerate Diagnostics, Inc. (NasdaqCM:AXDX ...

Accelerate Diagnostics, Inc. (NasdaqCM:AXDX) has an ERP5 rank of 17303. The ERP5 Rank is an investment tool that analysts use to ...